VEGFA and diabetic retinopathy: Vascular endothelial growth factor (VEGF) signaling plays an important role in the pathophysiology of nAMD and diabetic retinopathy [128], and current treatments of these conditions, such as intravitreal injection of anti-VEGF monoclonal antibodies, focus on targeting this pathway [129].